Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-16
2007-10-16
Allen, Marianne P. (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210
Reexamination Certificate
active
10154399
ABSTRACT:
The present invention is directed to a modified cell migration assay allowing for improved identification and discrimination of chemokine receptor antagonists from non-specific blockers.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5284753 (1994-02-01), Goodwin, Jr.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5942252 (1999-08-01), Tice et al.
patent: 6448054 (2002-09-01), Poznansky et al.
patent: 6451522 (2002-09-01), LaRosa
patent: 6689570 (2004-02-01), Andrew
patent: 6884574 (2005-04-01), Andrew
patent: 2003/0166143 (2003-09-01), Klein et al.
patent: WO 00/05265 (2000-02-01), None
On-Line Medical Dictionary http://cancerweb.ncl.ac.uk/omd/. Published at the Dept. of Medical Oncology, University of Newcastle upon Tyne, 1997-2004. The CancerWEB Project.
Haddad, J. Cytokines and related receptor-mediated signaling pathways. Biochemical and Biophysical Research Communications. vol. 297:700-713 (2002).
Gerard et al. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annual Review of Immunology vol. 12:775-808 (1994).
Bacon, K.B. et al., “Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid”,Br.J. Pharmacol., 1988, vol. 95, pp. 966-974.
Bender, A.M. et al., “Improved methods for the generation of dendritic cels from nonproliferating progenitors in human blood”,J. Immunol. Methods, 1996, vol. 196, pp. 121-135.
Campbell, J.J. et al., “6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7”,J.Cell Biol., 1998, vol. 141, pp. 1053-1059.
Cella, M. et al., “Maturation, activation, and protection of dendritic cells induced by double-stranded RNA”,J.Exp.Med., 1999, vol. 189, pp. 821-829.
Chan, V.W. et al., “Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells”,Blood, 1999, vol. 93, pp. 3610-3616.
Chen, S.H. et al., “Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo”,Proc. Natl. Acad. Sci. USA, 1994, vol. 91, pp. 3054-3057.
Dieu, M.C. et al., “Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites”,J.Exp.Med., 1998, vol. 188, pp. 373-386.
Forssmann, U. et al., “CKβ8, a novel CC chemokine that predominantly acts on monocytes”,FEBS Lett., 1997, vol. 408, pp. 211-216.
Kaufman, R.J., “Vectors used for expression in mammalian cells”,Methods Enzymol., 1990, vol. 185, pp. 487-511.
Kellermann, S.A. et al., “The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro- and in vivo-derived dendritic cells”,J.Immunol., 1999, vol. 162, pp. 3859-3864.
Kraal, G. et al., “Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody”,J.Exp.Med., 1986, vol. 163, pp. 981-997.
Penfold, M.E. et al., “Cytomegalovirus encodes a potent alpha chemokine”,Proc.Natl.Acad.Sci. USA, 1999, vol. 96, pp. 9839-9844.
Romani, N. et al., “Generation of mature dendritic cells for human blood. An improved method with special regard to clinical applicability”,J.Immunol. Methods, 1996, vol. 196, pp. 137-151.
Verdijk, R.M. et al., “Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells”,J.Immunol., 1999, vol. 163, pp. 57-61.
Youn, B.S. et al., “Characterization of CKβ8 and CKβ8-1: two alternatively spliced forms of human β-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1”,Blood, 1998, vol. 91, pp. 3118-3126.
Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, et al. 1987. Current protocols in molecular biology. John Wiley & Sons, New York.
Baggiolini et al., Annu. Rev. Immunol, 15: 675-705 (1997).
Baggiolini et al., Advances in Immunology, 55:97-179 (1994).
Deng, et al.,Nature, 381:661-666 (1996).
Hesselgesser et al., J Biol Chem 1998, 273(25):15687-92.
Horuk, Trends Pharm. Sci., 15:159-165 (1994).
Jayasena, S.D. 1999. Aptamers: an emerging class of molecules that rival antibodies in diagnostics.Clin Chem. 45:1628-50.
Jones, P.T., P.H. Dear, J. Foote, M.S. Neuberger, et al. 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse.Nature. 321:522-5.
Riechmann, L., M. Clark, H. Waldmann, and G. Winter. 1988. Reshaping human antibodies for therapy.Nature. 332-323-7.
Rossi, D., and A. Zlotnik. 2000. The Biology of Chemokines and their Receptors.Annu. Rev. Immunol. 18:217-242.
Verhoeyen, M., C. Milstein, and G. Winter. 1988. Reshaping human antibodies: grafting an antilysozyme activity.Science. 239: 1534-6.
Ancelin et al., Vascular Endothelial Growth Factor VEGF189 Induces Human Neutrophil Chemotaxis In Extravascular Tissue Via An Autocrine Amplification Mechanism.Laboratory Investigation. Feb. 16, 2004. pp. 502-512. vol. 84.
Behar et al., Neurotrophins Stimulate Chemotaxis of Embryonic Cortical Neurons.European Journal of Neuroscience. Jun. 18, 1997. pp. 2561-2570. vol. 9.
Ernst et al., An Annexin 1 N-Terminal Peptide Activates Leukocytes by Triggering Different Members of the Formal Peptide Receptor Family1.Journal of Immunology. Apr. 6, 2004. pp. 7669-7676. vol. 172.
Fiedler et al., To Go or Not to Go: Migration of Human Mesenchymal Progenitor Cells Stimulated by Isoforms of PDGF.Journal of Cellular Biochemistry. May 26, 2004, pp. 990-998. vol. 93.
Gutzmer et al., Human Monocyte-Derived Dendritic Cells Are Chemoattracted to C3a After Up-Regulation of the C3a Receptor with Interferons.Immunology. Jan. 9, 2004. pp. 435-443. vol. 111.
Haynes et al., Inhibition of C5a-Induced Neutrophil Chemotaxis and Macrophage Cytokine Production in Vitro by a New C5a Receptor Antagonist.Biochemical Pharmacology. Mar. 13, 2000. pp. 729-733. vol. 60.
Idzko et at., Nucleotides Induce Chemotaxis and Actin Polymerization in Immature But Not Mature Human Dendritic Cells Via Activation of Pertussis Toxin-Sensitive P2y Receptors.Immunobiology. Mar. 13, 2002. pp. 925-932. vol. 100, No. 3.
Klein et al., Identification of surrogate agonists for the human FPLR-1 receptor by autocrine selection in yeast.Nature Biotechnology. 1998. pp. 1334-1337. vol. 16.
Lamb et al., EGF Mediates Monocyte Chemotaxis and Macrophage Proliferation and EGF Receptor is Expressed in Atherosclerotic Plaques.Atherosclerosis. Apr. 20, 2004. pp. 21-26. vol. 176.
Ling et al., Histamine H4Receptor Mediates Eosinophil Chemotaxis with Cell Shape Change and Adhesion Molecule Upregulation.British Journal of Pharmacology. Feb. 9, 2004. pp. 161-171. vol. 142.
Migeotte et al., Identification and Characterization of an Endogenous Chemotactic Liquid Specific for FPRL2.Journal of Experimental Medicine. Jan. 3, 2005. pp. 83-93. vol. 201 No. 1.
Mimura et al., Inhibitory Effect of the 4-Aminotetrahydroquinoline Derivatives, Selective CRTH2 Antagonists, on Eosinophil Migration Induced by Prostaglandin D2.Journal of Pharmacology and Experimental Therapeutics. Mar. 29, 2005, as DOI:10.1124/jpet.104.081539.
Nakamura et al., Signals Via FGF Receptor 2 Regulate Migration of Endothelial Cells.Biochemical and Biophysical Research Communications. Nov. 9, 2001. pp. 801-806. vol. 289.
Polk et al., Epidermal and hepatocyte growth factors stimulate chemotaxis in an intestinal epithelial cell line.Am J. Physiol. 1999. pp. C1149-C1159. vol. 277.
Postma et al., Chemotaxis Inhibitory Protein ofStaphylococcus aureusBinds Specifically to the C5a and Formylated Peptide Receptor.Journal of Immunology. Mar. 18, 2004. pp. 6994-7001. vol. 172.
Rosenfeldt et al., The Sphingosine-I-Phosphate Receptor EDG-I is Essential for Platelet-Derived Growth Factor-Induced Cell Motility.Biochemical Society Transactions. Jun. 30, 2001. pp. 836-839. vol. 29, Part 6.
S
Miao Zhenhua
Wei Zheng
Allen Marianne P.
Brinks Hofer Gilson & Lione
ChemoCentryx, Inc.
DeBerry Regina M.
LandOfFree
Cell migration assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell migration assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell migration assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3881663